Advisor

Now showing items 1-1 of 1

Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy

Arevalo, J. Fernando (Stellenbosch : Stellenbosch University, 2018-12)

ENGLISH ABSTRACT: Bevacizumab is a complete full-length humanized antibody that binds to all subtypes of vascular endothelial growth factor (VEGF) and is used successfully in tumor therapy as a systemic drug. Recent ...